long covid

  1. forestglip

    Ongoing Symptoms After Acute SARS-CoV-2 or [flu] Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021–2023, 2025, Bullock+

    Ongoing Symptoms After Acute SARS-CoV-2 or Influenza Infection in a Case-Ascertained Household Transmission Study: 7 US Sites, 2021–2023 Ayla Bullock, Alexandra F Dalton, Melissa S Stockwell, Son H McLaren, Ellen Sano, Huong Q Nguyen, Suchitra Rao, Edwin Asturias, Karen Lutrick, Katherine D...
  2. forestglip

    Direct effects of prolonged TNF-α and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures, 2025, Goshi et al

    Direct effects of prolonged TNF-α and IL-6 exposure on neural activity in human iPSC-derived neuron-astrocyte co-cultures Noah Goshi, Doris Lam, Chandrakumar Bogguri, Vivek Kurien George, Aimy Sebastian, Jose Cadena, Nicole F. Leon, Nicholas R. Hum, Dina R. Weilhammer, Nicholas O. Fischer...
  3. forestglip

    Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a [RCT], 2025, Yuan et al

    Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients: 3-year follow-up of a randomized, double-blind, placebo-controlled trial Meng-Qi Yuan, Le Song, Ze-Rui Wang, Zi-Ying Zhang, Ming Shi, Junli He, Qiong Mo, Ning Zheng, Wei-Qi Yao, Yu Zhang, Tengyun Dong, Yuanyuan Li...
  4. forestglip

    Jitter and muscle fiber conduction velocity in long COVID fatigue, 2025, Kouyoumdjian et al

    Jitter and muscle fiber conduction velocity in long COVID fatigue João Aris Kouyoumdjian, Leticia Akemi Rama Yamamoto, Carla Renata Graca Background Long coronavirus disease (long COVID, LC) is defined as the continuation or development of new symptoms 3 months after the acute stage of severe...
  5. forestglip

    Review Anti-SARS-CoV-2 Antibodies in Long-COVID—Markers of Protection or Elevated Risk? A Systematic Review, 2025, Mink et al

    Anti-SARS-CoV-2 Antibodies in Long-COVID—Markers of Protection or Elevated Risk? A Systematic Review Sylvia Mink, Fabian Wilhelm, Janne Cadamuro, Patrick Reimann, Peter Fraunberger [Line breaks added] Abstract Long-COVID affects a significant number of COVID-19 survivors, profoundly impacting...
  6. forestglip

    Risk of [LC] and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study, 2025, Jooa et al

    Risk of Post-Acute Sequelae of COVID-19 and Oral Antivirals in Adults Aged Over 60 years: A Nationwide Retrospective Cohort Study Hyejin Jooa, Eunji Kimc, Kyungmin Huhd, Gi Hwan Baea, Hyungmin Leee, Jungyeon Kime, Dong-Hwi Kime, Min-Gyu Yooe, Il Uk Joi, Poong Hoon Leei, Geun Woo Leei, Hee Sun...
  7. forestglip

    Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients, 2025, Kato et al

    Prevalence of erectile dysfunction as long-COVID symptom in hospitalized Japanese patients Hideaki Kato, Nao Ichihara, Hiroki Saito, Shigeki Fujitani, Kohei Ota, Yuji Takahashi, Toshiyuki Harada, Takeshi Hattori, Mitsuru Komeya, Mariko Hosozawa, Yoko Muto, Miyuki Hori, Arisa Iba, Hiroyasu Iso...
  8. forestglip

    Interventions for Long COVID: A Narrative Review, 2025, Ivlev et al

    Interventions for Long COVID: A Narrative Review Ilya Ivlev, Jesse Wagner, Taylor Phillips, Jonathan R. Treadwell Abstract Long COVID continues to impose a significant burden on COVID-19 survivors, presenting with diverse symptoms and clinical uncertainty. This review synthesized evidence from...
  9. forestglip

    The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19, 2025, Ruhrländer et al

    The Orexin System and Its Impact on the Autonomic Nervous and Cardiometabolic System in Post-Acute Sequelae of COVID-19 Jana Ruhrländer, Styliani Syntila, Elisabeth Schieffer, Bernhard Schieffe [Line break added] Abstract Orexins (OXs) are critical for regulating circadian rhythms, arousal...
  10. forestglip

    Long COVID has variable incidence and clinical presentations: our 6-country collaborative study, 2025, Szabo et al

    Long COVID has variable incidence and clinical presentations: our 6-country collaborative study Sandor Szabo, Iryna Muzyka, Veronika Muller, Attila J. Szabo, Attila Szijártó, Klara Gyires, Tamas Doczi, Jozsef Janszky, Andreas Stengel, Siri Göpel, Antonia Trichopoulou, Rafael Diaz, Nicte...
  11. John Mac

    Trial Report The impact of long COVID on heart rate variability: a cross-sectional study, 2025, Seok-Ju Yoo et al

    Abstract Background Long-term COVID-19 (LC), which may affect the autonomic nervous system (ANS), is the term for the symptoms that some patients had for an additional month after contracting the virus. Therefore, during the LC phase, ANS status was evaluated in patients with mild-to-moderate...
  12. forestglip

    Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors [...], 2025, Rees et al

    Seasonal variation in the associations between self-reported long-COVID symptoms and IL-6 signalling-related factors (particularly the rs2228145 variant of the IL-6R gene): A clinical study. Katie Rees, Rebecca Aicheler, Lee Butcher, Alan Dodd, John Geen, Ceri Lynch, Isabel Massey, Keith...
  13. forestglip

    Exploring Heterogeneity of Fecal Microbiome in Long COVID Patients at 3 to 6 Months After Infection, 2025, Blankestijn et al

    Exploring Heterogeneity of Fecal Microbiome in Long COVID Patients at 3 to 6 Months After Infection Jelle M. Blankestijn, Nadia Baalbaki, Rosanne J. H. C. G. Beijers, Merel E. B. Cornelissen, W. Joost Wiersinga, Mahmoud I. Abdel-Aziz, Anke H. Maitland-van der Zee [Line breaks added] Abstract...
  14. forestglip

    Poor Association Between Clinical Characteristics and Seropositivity in Children With Suspected [LC]—A Single-Centre Study, 2025, Olsson-Åkefeld et al

    Poor Association Between Clinical Characteristics and Seropositivity in Children With Suspected Long COVID—A Single-Centre Study S. Olsson-Åkefeldt, J. Luthander, L. Anmyr, L. Villard, S. Arnason, M. K. Kemani, E. Wållgren, S. Röstlund, M. Tingborn, M. Pettersson, E. George, M. Ryd-Rinder, O...
  15. forestglip

    Identification of Putative Serum Autoantibodies Associated with [LC] via Comprehensive Protein Array Analysis, 2025, Hatayama et al

    Identification of Putative Serum Autoantibodies Associated with Post-Acute Sequelae of COVID-19 via Comprehensive Protein Array Analysis Yasuyoshi Hatayama, Kei Miyakawa, Yayoi Kimura, Kazuo Horikawa, Kouichi Hirahata, Hirokazu Kimura, Hideaki Kato, Atsushi Goto, Akihide Ryo [Line breaks...
  16. forestglip

    Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation, 2025, Daynes et al

    Post-Hospitalisation COVID-19 Rehabilitation (PHOSP-R): A randomised controlled trial of exercise-based rehabilitation Enya Daynes, Rachael A Evans, Neil J Greening, Nicolette C Bishop, Thomas Yates, Daniel Lozano-Rojas, Kimon Ntotsis, Matthew Richardson, Molly M Baldwin, Malik Hamrouni, Emily...
  17. forestglip

    Altered corticostriatal connectivity in long-COVID patients is associated with cognitive impairment, 2025, Troll et al

    Altered corticostriatal connectivity in long-COVID patients is associated with cognitive impairment Marie Troll, Meng Li, Tara Chand, Marlene Machnik, Tonia Rocktäschel, Antonia Toepffer, Johanna Ballez, Kathrin Finke, Daniel Güllmar, Jürgen R. Reichenbach, Martin Walter, Bianca Besteher...
  18. forestglip

    Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in [LC] Patients Compared to [No-LC] [...], 2025, Han+

    Circulating Autoantibodies Against Vasoactive Biomarkers Related to Orthostatic Intolerance in Long COVID Patients Compared to No-Long-COVID Populations: A Case-Control Study Emilie Han, Katrin Müller-Zlabinger, Ena Hasimbegovic, Laura Poschenreithner, Nina Kastner, Babette Maleiner, Kevin...
  19. forestglip

    Preprint Anticoagulant vs. antiviral therapy, recovery and neurodamage in Long COVID: a real-world prospective cohort study, 2025, Jamoulle et al

    Anticoagulant vs. antiviral therapy, recovery and neurodamage in Long COVID: a real-world prospective cohort study Marc Jamoulle, Margaux Mignolet, Isabelle Meyts, Aurelie Ladang, Charles Nicaise, Johan Van Weyenbergh [Line breaks added] Abstract Recent estimates consider that Long COVID...
  20. ahimsa

    The Sick Times: Government resources about Long COVID as a disability (USA)

    Article from The Sick Times: Now offline: Government resources about Long COVID as a disability (headline refers to the US government)
Back
Top Bottom